Pilot Gene Technologies (Hangzhou) Co.
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $32M
Investors
- 7
About Pilot Gene Technologies (Hangzhou) Co.
, Ltd is a technology company that engages in the research and development of life science products. The company has a research and development center and a GMP production base. As of 2023, it has more than 80 independent intellectual property rights. The company mainly provides digital PCR detection systems that integrate droplet generation, PCR amplification, and multi-channel fluorescence detection. In addition, it also provides related digital PCR consumables and reagents. The company's products can be applied to the detection of pathogenic microorganisms, tumor liquid biopsy, reproduction and genetics, and other fields.
Who invested in Pilot Gene Technologies (Hangzhou) Co.
7 investors across 4 rounds
See all investors in Pilot Gene Technologies (Hangzhou) Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pilot Gene Technologies (Hangzhou) Co.
Who invested in Pilot Gene Technologies (Hangzhou) Co.?
Pilot Gene Technologies (Hangzhou) Co. has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pilot Gene Technologies (Hangzhou) Co. raised?
Pilot Gene Technologies (Hangzhou) Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Pilot Gene Technologies (Hangzhou) Co. last raise money?
Pilot Gene Technologies (Hangzhou) Co.'s most recent round on record is a Series B, in Sep 2023.
What does Pilot Gene Technologies (Hangzhou) Co. do?
, Ltd is a technology company that engages in the research and development of life science products.
Where is Pilot Gene Technologies (Hangzhou) Co. headquartered?
Pilot Gene Technologies (Hangzhou) Co. is headquartered in Hangzhou, China.
Which VCs invest in companies like Pilot Gene Technologies (Hangzhou) Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Pilot Gene Technologies (Hangzhou) Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Pilot Gene Technologies (Hangzhou) Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.